| Literature DB >> 33177063 |
Peter W Janes1, Mary E Vail2, Matthias Ernst3, Andrew M Scott2.
Abstract
The tumor microenvironment (TME) promotes tumor development via complex intercellular signaling, aiding tumor growth and suppressing immunity. Eph receptors (Eph) and their ephrin ligands control cell interactions during normal development, and reemerge in tumors and the TME, where they are implicated in invasion, metastasis, and angiogenesis. Recent studies also indicate roles for Ephs in suppressing immune responses by controlling tumor interactions with innate and adaptive immune cells within the TME. Accordingly, inhibiting these functions can promote immune response and efficacy of immune checkpoint inhibition. This research highlights Ephs as potential targets to enhance efficacy of immune-based therapies in patients with cancer. ©2020 American Association for Cancer Research.Entities:
Year: 2020 PMID: 33177063 DOI: 10.1158/0008-5472.CAN-20-3047
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701